Disponibilidad en nuestra farmacia online: Papilocare está disponible para su compra en nuestra farmacia online, ofreciendo comodidad y discreción a nuestros clientes.

O imbunatatire a procesului de vindecare atunci cand este utilizat ca si coadjuvant in tratamentul leziunilor intraepiteliale cauzate de HPV la nivelul mucoasei cervico-vaginale. Xem thêm: Thuốc Vitrex Plus có tác dụng gì? Giá bao nhiêu? Mua ở đâu. Hướng dẫn cách sử dụng Papilocare Gel Vaginal Liều dùng Gel je indikovan za hidrataciju i obnavljanje sluzokože genitalne zone kojoj je potrebna posebna nega nakon određenih medicinsko-hirurških zahvata (na primer, nakon laserskog uklanjanja genitalnih kondiloma ili bradavica koje izaziva HPV). Papilocare contiene una combinación única de ingredientes naturales y científicamente probados que trabajan en conjunto para abordar las lesiones causadas por el VPH y promover un entorno vaginal saludable. Algunos de los principales ingredientes de Papilocare incluyen:Neem extract): има омекотяващо действие, което засилва естествения процес на заздравяване и намалява зачервяването и сърбежа. Ana, 28 años: «Usé Papilocare como parte de mi tratamiento para el VPH y las verrugas genitales. No solo ayudó a reducir las verrugas, sino que también mejoró mi salud vaginal en general. Me siento mucho más cómoda y segura ahora que estoy usando este producto». Estudios científicos y respaldo médico

Proprietatile gelului vaginal permit: formarea unei bariere de aparare in zona de transformare a colului uterin pentru a preveni riscul de patrundere a HPV si o imbunatatire a procesului de vindecare atunci cand este utilizat ca si coadjuvant in tratamentul leziunilor intraepiteliale cauzate de HPV la nivelul mucoasei cervico-vaginale. Amennyiben a Papilocare®-el kapcsolatban mellékhatást vagy minőségi reklamációt szeretne bejelenteni, a következő lehetőségek bármelyikén megteheti: Approximately 30% of Spanish women younger than 30 years are HPV carriers. 25 The likelihood of HPV infection decreases over time, from 47% between the ages of 15 and 19 years to 12% in women older than 45 years. 26 The HPV is a fundamental factor for the development of cervical cancer. 27 The World Health Organization has recently established the elimination of cervical cancer as a priority medium-term objective. 28 This trial aimed to explore whether treatment with Papilocare provides better results than the conventional watchful waiting strategy in improving low-grade cervical lesions, which are the first step in the natural history of cervical cancer. 29 Clearance of LSILs after a conservative approach is of approximately 59% within 2 years of the diagnosis. Nevertheless, the likelihood of progression of these lesions to a high-grade squamous intraepithelial lesion within 5 years is 12.7%. 30 In addition, treatments for cervical cancer severely compromise the reproductive health of women. In a systematic review of Cochrane, Kyrgiou et al. 31 demonstrated a higher baseline risk for prematurity in women with cervical intraepithelial neoplasia, which increased with excisional and ablative treatments. Therefore, the scenario is conflicting, as choosing an excisional or ablative approach for the treatment of LSILs can result in negative reproductive outcomes, but avoiding treatment and just monitoring the disease results in its progression to high-grade lesions in 12 of 100 women. The current recommendation in Spain also includes monitoring the disease. 32, 33 However, based on the results of this present study, a novel strategy involving Papilocare has become available. The results of this treatment in the repair of low-grade lesions have demonstrated to significantly exceed those obtained with the watchful waiting approach (8 in 10 women achieved a normalization in their lesions).Gel reepitelizant al zonei de transformare a colului uterin pentru prevenirea si tratamentul coadjuvant al leziunilor cauzate de HPV. Repair of HPV-dependent cervical lesions after 3 and 6 months of treatment in the total and HR HPV patient pools. *Normalized cytology together with concordant colposcopic observations. **χ 2 test. One high-risk HPV patient of the control group had missing data. Overall HPV Clearance Es importante seguir las recomendaciones del médico y no interrumpir el tratamiento antes de tiempo, incluso si los síntomas parecen haber mejorado, ya que esto puede resultar en una recurrencia de las lesiones del VPH. Posibles efectos secundarios y precauciones

Adopte una posición cómoda, preferiblemente acostada o de pie con una pierna levantada y apoyada en una superficie elevada.

Papilocare 7 (7x5ml)

Tratamentul durează 6 luni, iar dacă este necesar mai mult, conform indicațiilor medicului. Pentru atingerea dorită hialurónico: Este ingrediente es conocido por sus propiedades hidratantes y regenerativas, ayudando a mantener la mucosa vaginal saludable y protegida.